These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33038488)

  • 21. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
    Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
    Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYC and metabolism on the path to cancer.
    Hsieh AL; Walton ZE; Altman BJ; Stine ZE; Dang CV
    Semin Cell Dev Biol; 2015 Jul; 43():11-21. PubMed ID: 26277543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
    Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
    Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A newly synthesized oleanolic acid derivative inhibits the growth of osteosarcoma cells in vitro and in vivo by decreasing c-MYC-dependent glycolysis.
    Gao F; Zuo Q; Jiang T; Song H; Zhou J
    J Cell Biochem; 2019 Jun; 120(6):9264-9276. PubMed ID: 30552712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway.
    Zhang G; Jin C; Zhu Y; Fu F; Wang G; Li S
    Life Sci; 2020 Dec; 263():118485. PubMed ID: 33017573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.
    Li Z; Liu H; Li B; Zhang Y; Piao C
    Cell Biochem Biophys; 2015 Jul; 72(3):719-26. PubMed ID: 25627547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
    Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
    Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
    Abu Aboud O; Donohoe D; Bultman S; Fitch M; Riiff T; Hellerstein M; Weiss RH
    Am J Physiol Cell Physiol; 2015 Jun; 308(11):C890-8. PubMed ID: 25810260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
    Liao D; Zhong L; Yin J; Zeng C; Wang X; Huang X; Chen J; Zhang H; Zhang R; Guan XY; Shuai X; Sui J; Gao S; Deng W; Zeng YX; Shen JN; Chen J; Kang T
    Nat Cell Biol; 2020 Jul; 22(7):868-881. PubMed ID: 32483387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.
    Wang L; Yu Z; Ren S; Song J; Wang J; Du G
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2281-2292. PubMed ID: 30036603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.
    Zhang H; Guo X; Feng X; Wang T; Hu Z; Que X; Tian Q; Zhu T; Guo G; Huang W; Li X
    Oncotarget; 2017 Jan; 8(2):2342-2355. PubMed ID: 27911265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
    Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
    Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
    Yao Q; Pei Y; Zhang X; Xie B
    Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
    Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
    Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
    Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
    Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression.
    Zhan W; Liao X; Wang Y; Li L; Li J; Chen Z; Tian T; He J
    Carcinogenesis; 2019 Jun; 40(4):560-568. PubMed ID: 30403769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.
    Fang Y; Shen ZY; Zhan YZ; Feng XC; Chen KL; Li YS; Deng HJ; Pan SM; Wu DH; Ding Y
    Nat Commun; 2019 Sep; 10(1):3981. PubMed ID: 31484922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.